Semaglutide Overview
Read the focused GLP1Scientist research page for this semaglutide question.
Open researchSEMAGLUTIDE SAFETY
Semaglutide Side Effects: Common and Serious Risks
Semaglutide safety information spans common gastrointestinal effects, serious labeled risks, rare events and evolving pharmacovigilance findings.
Safety note: Severe, persistent, rapidly worsening or otherwise concerning symptoms require assessment by an appropriately licensed healthcare professional. GLP1Scientist does not diagnose symptoms, determine causation or recommend medication changes.
Video explainer
Understanding GLP-1 Effects on the Body
Research analysis
Semaglutide Side Effects: Common and Serious Risks
The most consistently reported semaglutide adverse effects are gastrointestinal, particularly nausea, vomiting, diarrhoea and constipation. Serious events are less common and require product-specific regulator evidence. A general web page cannot determine whether an individual symptom is caused by semaglutide. PubMed.
Common gastrointestinal effects
Nausea, vomiting, diarrhoea and constipation were among the most frequently reported effects in randomized semaglutide weight-loss trials. PubMed.
Treatment discontinuation
The same meta-analysis reported higher discontinuation because of adverse events among semaglutide-treated participants. PubMed.
Serious adverse events
Uncommon events should not be presented as nonexistent, while reported events should not automatically be described as proven causal effects.
Post-marketing surveillance
WHO emphasized continued post-marketing surveillance as GLP-1 use expands. WHO.
Ophthalmic safety
EMA materials include NAION as a very rare semaglutide safety issue requiring frequency-qualified wording. EMA.
When online information is insufficient
GLP1Scientist does not diagnose symptoms, recommend stopping treatment, changing dose or switching medicines.
Broader research resources
Separate men's health information is available through broader men's health research and broader men's performance product research. These links are separated from safety guidance and are not treatment resources.
Sources and references
See also the research methodology, corrections policy, medical disclaimer and affiliate disclosure.
Frequently asked questions
Questions about this topic
What are the most common side effects?
Nausea, vomiting, diarrhoea and constipation are among the most consistently reported effects.
Are serious side effects common?
Serious adverse events were uncommon in the referenced randomized-trial meta-analysis, although product-specific warnings remain important.
Can semaglutide cause eye problems?
EMA has identified NAION as a very rare semaglutide safety issue.
When should someone seek medical help?
Severe, persistent or worsening symptoms warrant professional medical assessment.
About the author
Research direction by Dr. Rahul Dev
Dr. Rahul Dev is a data scientist, patent attorney, life-sciences researcher and global business strategist with more than 20 years of professional experience. He founded GLP1Scientist to organize complex GLP-1 evidence, regulatory information, market data, patent intelligence and commercial developments into a connected global research platform.
Dr. Rahul Dev is not a physician. GLP1Scientist does not provide diagnosis, prescribing, medical care or individualized treatment recommendations.